Detailed View

ECVT - Ecovyst Inc.

Latest filing: 2026-03-31 | Reporting: gaap

Open Yahoo Financials (ECVT)

Back to Dashboard
Market Cap
1,417,422,592
Adj EBIT (TTM)
45,362,000
Enterprise Value
1,647,634,592
Last Price
12.95
Earnings Yield
2.75%
Return on Capital
6.17%
Capital
735,361,000

1Y Price Chart

Last Price: -
1Y Change: -

Company Summary

Ecovyst Inc. provides specialty silica catalysts and sulfuric acid recycling services, with its Ecoservices division operating regeneration facilities that process spent sulfuric acid from petroleum refining customers, and its Catalyst Technologies division supplying zeolite and silica-based catalysts used in polyethylene and polypropylene production. The business model is B2B industrial services and materials, with long-term contracted relationships with oil refiners and petrochemical manufacturers who rely on Ecovyst for continuous acid regeneration and catalyst supply. Revenue is approximately $600-650M annually, with operations concentrated primarily in North America, particularly along the U.S. Gulf Coast refining corridor.

Past Year Trends

  • Ecovyst completed the sale of its Advanced Materials & Catalysts segment to Technip Energies for $556 million in late 2025, using $465 million of proceeds to retire term loan debt and reducing net leverage to 1.2x from a significantly higher level, fundamentally reshaping the company into a pure-play sulfuric acid and polyethylene catalyst business. (Bullish)
  • Full-year 2025 revenue reached $723.5 million with Q4 2025 sales of $199.4 million, a 34% increase versus Q4 2024 sales of $148.9 million, driven by recovery in refinery services and sulfuric acid regeneration demand after a soft 2024. (Bullish)
  • Ecovyst acquired the Wagaman sulfuric acid assets for approximately $40 million, adding roughly 10% to overall sulfuric acid volume capacity, while polyethylene catalyst sales in 2025 came in below prior forecasts due to softer-than-expected customer demand. (Neutral)

Next Year Trends

  • Ecovyst raised its full-year 2026 sales guidance to $890 million–$970 million (up from the initial $860 million–$940 million range) following Q1 2026 sales of $215 million, a 50% year-over-year increase, with average selling prices benefiting from approximately $33 million in pass-through sulfur cost escalation and higher virgin sulfuric acid contract pricing. (Bullish)
  • Management flagged expected reductions in virgin sulfuric acid volumes and elevated scheduled turnaround costs in Q3 and Q4 2026 that are anticipated to constrain second-half Adjusted EBITDA, creating a back-half earnings risk within the $180 million–$195 million full-year Adjusted EBITDA guidance range. (Bearish)
  • Integration of the Wagaman sulfuric acid assets, which carried cost headwinds through 2025, is expected to turn accretive to earnings and free cash flow in 2026, with free cash flow guidance of $35 million–$55 million representing the first meaningful free cash flow generation since the company's restructuring. (Bullish)

Red Flags

No severe red flags identified as of August 2025.

Updated 2026-05-21

endDateformTypefiscalYearRevenueOperatingIncomeLoss
2026-03-3110-Q2026214,952,00012,537,000
2025-12-3110-K (Q4 derived)2025-367,798,000-23,361,000
2025-09-3010-Q2025204,907,00028,275,000
2025-06-3010-Q2025200,128,00017,809,000
2025-03-3110-Q2025162,197,000-912,000
2024-12-3110-K (Q4 derived)2024181,961,00024,752,000
2024-09-3010-Q2024179,175,00031,541,000
2024-06-3010-Q2024182,820,00027,848,000

Notice something wrong?

Submit a quick report with a snapshot of the values you are seeing.